4//SEC Filing
Nichols David Wayne 4
Accession 0000899243-22-018807
CIK 0001690585other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 4:20 PM ET
Size
5.5 KB
Accession
0000899243-22-018807
Insider Transaction Report
Form 4
Nichols David Wayne
Chief Technical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-05-17+50,000→ 50,000 totalExercise: $1.18Exp: 2032-05-16→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable in three equal installments, each installment vesting every six months, over the 18 months following the vesting commencement date. The vesting commencement date is May 15, 2022.
Documents
Issuer
Magenta Therapeutics, Inc.
CIK 0001690585
Entity typeother
Related Parties
1- filerCIK 0001857488
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 4:20 PM ET
- Size
- 5.5 KB